Recent advances in developing small-molecule inhibitors against SARS-CoV-2
The COVID-19 pandemic caused by the novel SARS-CoV-2 virus has caused havoc across the entire world. Even though several COVID-19 vaccines are currently in distribution worldwide, with others in the pipeline, treatment modalities lag behind. Accordingly, researchers have been working hard to underst...
Saved in:
Main Authors: | Rong Xiang (Author), Zhengsen Yu (Author), Yang Wang (Author), Lili Wang (Author), Shanshan Huo (Author), Yanbai Li (Author), Ruiying Liang (Author), Qinghong Hao (Author), Tianlei Ying (Author), Yaning Gao (Author), Fei Yu (Author), Shibo Jiang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics
by: Chris Chun-Yiu Chan, et al.
Published: (2024) -
Reducing SARS-CoV-2 pathological protein activity with small molecules
by: Donata Pluskota-Karwatka, et al.
Published: (2021) -
Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules
by: Kenana Al Adem, et al.
Published: (2020) -
Recent Research Advances in Small-Molecule Pan-PIM Inhibitors
by: Lei Xu, et al.
Published: (2022) -
Rational Design of A Novel Small-Molecule HIV-1 Inactivator Targeting Both gp120 and gp41 of HIV-1
by: Jing Pu, et al.
Published: (2021)